Analyst Price Target is $10.00
▲ +880.39% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Creative Medical Technology in the last 3 months. The average price target is $10.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 880.39% upside from the last price of $1.02.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Creative Medical Technology.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.